Evaluation of masitinib combined to gemcitabine, carboplatin or capecitabine in patients with a metastatic or locally advanced breast cancer relapsing after a first chemotherapy treatment Zhodno...

Update Il y a 4 ans
Reference: EUCTR2010-022646-24

Evaluation of masitinib combined to gemcitabine, carboplatin or capecitabine in patients with a metastatic or locally advanced breast cancer relapsing after a first chemotherapy treatment Zhodnotenie masitinibu v kombinácii s gemcitabínom, karboplatinou alebo kapecitabínom u pacientok s metastatickou alebo lokálne pokročilou rakovinou prsníka po prvej liečbe chemoterapiou

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Overall Survival (OS) Celkové prežitie (OS)


Inclusion criteria

  • Metastatic or locally advanced breast cancer ,Metastatická alebo lokálne pokročilá rakovina prsníka